pegylated interferon-alfa 2a

Drug identity checked against registry records

Also recorded as PEG-IFNα; pegylated interferon alpha-2a

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus InfectionNCT04412863VIRPhase 2Completed2024-03-25Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.